Medifirst Solutions, Inc. (MFST) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
4400 ROUTE 9 SOUTH FREEHOLD, NJ 07728 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2019 MRQ | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 83 | 288 | 165 | 157 | 1 | 4 | |||
| Cash and cash equivalents | 83 | 288 | 165 | 157 | 1 | 4 | |||
| Receivables | 2 | ||||||||
| Inventory, net of allowances, customer advances and progress billings | 33 | 33 | 14 | 50 | 5 | 8 | |||
| Inventory | 33 | 33 | 14 | 50 | 5 | 8 | |||
| Prepaid expense | 16 | 1 | 3 | ||||||
| Total current assets: | 116 | 321 | 195 | 207 | 9 | 14 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 1 | 1 | 2 | 2 | 6 | 5 | |||
| Intangible assets, net (including goodwill) | 101 | 116 | 138 | ✕ | |||||
| Intangible assets, net (excluding goodwill) | 101 | 116 | 138 | ||||||
| Other undisclosed noncurrent assets | 1 | 1 | 1 | 1 | 0 | ||||
| Total noncurrent assets: | 102 | 118 | 140 | 2 | 7 | 5 | |||
| TOTAL ASSETS: | 219 | 439 | 335 | 209 | 16 | 19 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 222 | 98 | 75 | 124 | 319 | 232 | |||
| Accrued liabilities | 389 | 401 | 405 | 370 | |||||
| Other undisclosed accounts payable and accrued liabilities | (167) | (303) | (330) | (246) | 319 | 232 | |||
| Debt | 531 | 295 | 161 | 205 | 53 | 52 | |||
| Derivative instruments and hedges, liabilities | 263 | 252 | 145 | 158 | |||||
| Due to related parties | 9 | 9 | 9 | 9 | 6 | ||||
| Other undisclosed current liabilities | 440 | 535 | 797 | 370 | |||||
| Total current liabilities: | 1,465 | 1,188 | 1,186 | 865 | 378 | 284 | |||
| Noncurrent Liabilities | |||||||||
| Total liabilities: | 1,465 | 1,188 | 1,186 | 865 | 378 | 284 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | (1,246) | (749) | (852) | (656) | (362) | (265) | |||
| Preferred stock | 0 | ||||||||
| Common stock | 0 | 85 | 23 | 4 | 2 | 1 | |||
| Additional paid in capital | 3,487 | 2,831 | 1,233 | 310 | 259 | 64 | |||
| Accumulated deficit | (4,734) | (3,665) | (2,107) | (970) | (623) | (330) | |||
| Other undisclosed equity, attributable to parent | 0 | 0 | 0 | 0 | |||||
| Total equity: | (1,246) | (749) | (852) | (656) | (362) | (265) | |||
| TOTAL LIABILITIES AND EQUITY: | 219 | 439 | 335 | 209 | 16 | 19 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 29 | 30 | 2 | 86 | 54 | |||
| Revenue, net | ✕ | ✕ | 30 | 80 | 13 | |||
| Other operating income | 23 | |||||||
| Financial services revenue | ✕ | ✕ | 2 | 42 | ||||
| Cost of revenue | (1) | (1) | (5) | (50) | (1) | |||
| Cost of goods and services sold | (1) | (1) | (1) | (0) | ||||
| Gross profit: | 28 | 29 | (3) | 35 | 54 | |||
| Operating expenses | (793) | (981) | (734) | (244) | (326) | (167) | ||
| Operating loss: | (764) | (952) | (734) | (248) | (290) | (113) | ||
| Nonoperating income (expense) | 0 | 0 | (292) | (1) | ||||
| Investment income, nonoperating | 0 | 0 | ||||||
| Other nonoperating expense | (292) | (1) | ||||||
| Interest and debt expense | (647) | (405) | (647) | (93) | (2) | (1) | ||
| Loss from continuing operations before equity method investments, income taxes: | (1,411) | (1,357) | (1,380) | (340) | (584) | (116) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 342 | (201) | 243 | |||||
| Loss from continuing operations before income taxes: | (1,069) | (1,558) | (1,138) | (340) | (584) | (116) | ||
| Income tax expense | (1) | |||||||
| Loss from continuing operations: | (1,069) | (1,558) | (1,138) | (340) | (585) | (116) | ||
| Loss before gain (loss) on sale of properties: | (1,069) | (1,558) | (1,138) | (340) | (585) | (116) | ||
| Other undisclosed net income | 3,245 | 1,304 | ||||||
| Net income (loss): | (1,069) | (1,558) | 2,107 | 964 | (585) | (116) | ||
| Other undisclosed net income (loss) attributable to parent | (3,245) | (1,308) | 292 | 1 | ||||
| Net loss available to common stockholders, diluted: | (1,069) | (1,558) | (1,138) | (344) | (293) | (115) | ||
Comprehensive Income ($ in thousands)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (1,069) | (1,558) | 2,107 | 964 | (585) | (116) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (1,069) | (1,558) | 2,107 | 964 | (585) | (116) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.